Literature DB >> 26629235

Sympathetic renal denervation in hypertension with chronic kidney disease: a case report and review of literature.

Yingyi Wu1, Suyan Duan2, Xuxue Qiang2, Zhangcheng Ning2, Changying Xing2, Bo Zhang2.   

Abstract

Resistant hypertension is defined as systolic blood pressure that is higher than 140 mmHg even though they consume three maximally tolerated anti-hypertensive medication class, including diuretics at an appropriate dose [1]. There are many complications of resistant hypertension such as left ventricular hypertrophy, increased incidence of retinal hemorrhage and kidney damages [2]. A novel catheter-based technique for renal denervation (RDN) as a new therapeutic avenue has great promise for the treatment of refractory hypertension. Despite the fast pace of development in RDN therapies, only initial and very limited clinical data are available. Here, we present the effects of RDN on perivascular nerves of the renal arteries in a 62-year-old male patient. And large gaps in knowledge concerning the long-term effects and consequences of RDN still exist, and solid, randomized data are warranted.

Entities:  

Keywords:  Renal denervation; chronic kidney disease; renal sympathetic nervous system; resistant hypertension

Year:  2015        PMID: 26629235      PMCID: PMC4659123     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.

Authors:  Felix Mahfoud; Bodo Cremers; Julia Janker; Britta Link; Oliver Vonend; Christian Ukena; Dominik Linz; Roland Schmieder; Lars Christian Rump; Ingrid Kindermann; Paul Andrew Sobotka; Henry Krum; Bruno Scheller; Markus Schlaich; Ulrich Laufs; Michael Böhm
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

2.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

Review 3.  Pathophysiology I: the kidney and the sympathetic nervous system.

Authors:  Rosa L de Jager; Peter J Blankestijn
Journal:  EuroIntervention       Date:  2013-05       Impact factor: 6.534

Review 4.  Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.

Authors:  Eva E Vink; Rosa L de Jager; Peter J Blankestijn
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

Review 5.  Resistant hypertension--its identification and epidemiology.

Authors:  Pantelis A Sarafidis; Panagiotis Georgianos; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

6.  Prevalence of apparent treatment-resistant hypertension among individuals with CKD.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; David Warnock; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-18       Impact factor: 8.237

7.  Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage.

Authors:  Cesare Cuspidi; Stefano Meani; Veronica Fusi; Cristiana Valerio; Carla Sala; Alberto Zanchetti
Journal:  J Hypertens       Date:  2006-03       Impact factor: 4.844

8.  Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

Review 9.  Resistant hypertension: an overview of evaluation and treatment.

Authors:  Pantelis A Sarafidis; George L Bakris
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more
  2 in total

1.  The association of endothelin-1 gene polymorphism and its plasma levels with hypertension and coronary atherosclerosis.

Authors:  Nazanin Ebrahimi; Gholamreza Asadikaram; Abbas Mohammadi; Yunes Jahani; Mina Moridi; Mohammad Masoumi
Journal:  Arch Med Sci       Date:  2019-07-22       Impact factor: 3.318

2.  Catheter-based renal sympathetic nerve denervation on hypertension management outcomes.

Authors:  Som P Singh; Kevin J Varghese; Fahad M Qureshi; Macy C Anderson; John Foxworth; Mark M Knuepfer
Journal:  World J Radiol       Date:  2022-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.